China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE000000Q94
China Resources Double-Crane Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 11.21 bn CNY | 11.00 bn CNY |
| Gross profit | 6.38 bn CNY | 6.38 bn CNY |
| Operating income | 1.83 bn CNY | 1.86 bn CNY |
| EBIT | 1.88 bn CNY | 1.94 bn CNY |
| Net income | 1.63 bn CNY | 1.65 bn CNY |
| Diluted EPS – continuing operations | 1.58 CNY | 1.59 CNY |
Full history since 1994, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About China Resources Double-Crane Pharmaceutical Co Ltd
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.
More stocks
- Big Yellow Group PLC (BYG.L)
- Shanghai Suochen Information Technology Co. Ltd. A (688507.SS)
- Fibra Danhos (DANHOS13.MX)
- Maple Leaf Foods Inc (MFI.TO)
- KWS SAAT SE & Co KgaA (KWS.DE)
- Top Choice Medical Investment Co Inc (600763.SS)
- Sunway Construction Group Bhd (5263.KL)
- BOSTON BEER CO INC (SAM)
- Indosat Tbk (ISAT.JK)
- Munters Group AB (MTRS.ST)
- InvenTrust Properties Corp. (IVT)
- TRINITY INDUSTRIES INC (TRN)
Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.